We are creating the world's most trusted encyclopedia and knowledge base. Once you join us and log in, you'll be able to edit this page instantly!

From Citizendium, the Citizens' Compendium

(Two by two table for reducing {{{1}}} in this randomized controlled trial using a Clinical calculator. The calculator will let you adjust for patients at different risks of outcomes - Under construction).

Contents 1 Notes on use 1.1 Parameters 1.2 Examples 2 2x2-rx URLs 3 References

Notes on use

Under construction. Once working well and also vetted, this program can be moved from UTHSCSA to Citizendium. The 2x2-rx template helps markup links to http://medinformatics.uthscsa.edu/calculator/, a clinical calculator that includes calculations for randomized controlled trials and studies of the sensitivity and specificity of tests.

Parameters

1. REQUIRED - outcome
2. REQUIRED - the value for cell A
3. REQUIRED - the value for cell B
4. REQUIRED - the value for cell C
5. REQUIRED - the value for cell D
6. REQUIRED - the value for row 1 total
7. REQUIRED - the value for row 2 total

Examples

Example for the randomized controlled trial of gemfibrozil for reducing cardiovascular events:^[1]

Markup  {{2x2-rx|cardiovascular events|219|1045|275|992|1264|1267}}
Giving (Two by two table for reducing cardiovascular events in this randomized controlled trial using a Clinical calculator. The calculator will let you adjust for patients at different risks of outcomes - Under construction).

See hypoalphalipoproteinemia for an example.

2x2-rx URLs

This template configures the url for: http://medinformatics.uthscsa.edu/calculator/calc.shtml

References

1. ↑ Rubins HB, Robins SJ, Collins D, et al (1999). "Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group". N. Engl. J. Med. 341 (6): 410–8. PMID 10438259.